CD34 and myeloproliferative disorder: Furthermore, we also noticed that the features from patients with three JAK2V617F+ MPN entities were less uniform than those of HC (Figure 1A), indicating the heterogeneity of CD34+ HSPCs existed not only between different MPN subtypes but also in the same MPN subtype.